Zobrazeno 1 - 10
of 13
pro vyhledávání: '"EA Dmitrieva"'
Autor:
Evgeniy Vladimirovich Pochtar, EA Dmitrieva, E V Naumova, A I Kostin, S A Lugovskaya, Dolgov Vv
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 66(6)
Profound immunological dysfunction is the key factor determining the development of infectious complications in chronic lymphocytic leukemia (CLL). The aim of this work is to assess the features of the subpopulation composition of T-lymphocytes (T-he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f923c313b47487aa515467f5a7bbeef
https://pubmed.ncbi.nlm.nih.gov/34105910
https://pubmed.ncbi.nlm.nih.gov/34105910
Autor:
NYu Dmitrieva, Aston Consulting, bld. Shabolovka str., Moscow, Russian Federation, Vadim V. Ptushkin, EA Dmitrieva, E A Nikitin, EE Markova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 4, Pp 438-448 (2019)
Background. Infections are a common complication of chronic lymphocytic leukemia (CLL). The lack of recommendations for infection prevention in CLL patients treated with ibrutinib can be attributed by an insufficiency of data in the literature. Aim.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c85f388ac48690b028923b408e70834
https://doaj.org/article/44e0e17f7d15430a8fb59afc6d6bd3ff
https://doaj.org/article/44e0e17f7d15430a8fb59afc6d6bd3ff
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 2, Pp 220-230 (2019)
Aim. Early diagnosis and treatment of rhythm and conduction disorders in patients receiving ibrutinib. Materials & Methods. The trial included 206 patients with indications for ibrutinib, 193 of them are at different stages of treatment from 1.5 to 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c08ba70a33a7a4134b323877ec41964
https://doaj.org/article/d326e9f0f85647709ff2f752c195c457
https://doaj.org/article/d326e9f0f85647709ff2f752c195c457
Publikováno v:
Kardiologiia. 17:51-60
Background. Chronic lymphocytic leukemia (CLL) remains an uncurable disease, in which the age, number and severity of comorbidities primarily determine the choice of therapeutic tactics and objectives. Aim. To evaluate actual comorbidity and polymorb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d317c176b584b9c0176233114e0ea05
https://doi.org/10.18087/cardio.2568
https://doi.org/10.18087/cardio.2568
Autor:
AV Shubina, OYu Vinogradova, E. I. Emelina, GE Gendlin, MA Panteleev, MM Pankrashkina, E A Nikitin, Vadim V. Ptushkin, S A Lugovskaya, EA Dmitrieva, EE Markova, EG Arshanskaya, VV Glazunova, T N Obukhova, NK Khuazheva, Pochtar' Me, Valentina Ivanova, NG Novitskaya, YuB Kochkareva, LA Mukha, IE Lazarev, E. V. Naumova, SA Chernysh
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 271-281 (2017)
Background & Aims. This paper presents the results of the observational study of ibrutinib in patients with chronic lymphocytic leukemia (CLL), conducted in SP Botkin Municipal Clinical Hospital. The main objective was the analysis of complications o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c195876623d9edb1dbb58aad28254f
https://doi.org/10.21320/2500-2139-2017-10-3-271-281
https://doi.org/10.21320/2500-2139-2017-10-3-271-281
Autor:
Kislova M; Botkin Hospital, Moscow, Russia., Petrenko A; Botkin Hospital, Moscow, Russia.; Russian Medical Academy of Continuous Medical Education, Moscow, Russia., Dmitrieva EA; Botkin Hospital, Moscow, Russia., Milenkin A; Moscow Institute of Physics and Technology, Moscow, Russia., Nikitin KE; Moscow Institute of Physics and Technology, Moscow, Russia., Ptushkin VV; Botkin Hospital, Moscow, Russia.; Russian Medical Academy of Continuous Medical Education, Moscow, Russia., Shabunin AV; Botkin Hospital, Moscow, Russia.; Russian Medical Academy of Continuous Medical Education, Moscow, Russia., Nikitin EA; Botkin Hospital, Moscow, Russia.; Russian Medical Academy of Continuous Medical Education, Moscow, Russia.
Publikováno v:
Hematological oncology [Hematol Oncol] 2023 Oct; Vol. 41 (4), pp. 683-693. Date of Electronic Publication: 2023 Apr 14.
Autor:
Kochneva ОL; City Clinical Hospital No. 52, Moscow, Russia., Kislova M; Botkin Hospital, Moscow, Russia., Zhelnova EI; City Clinical Hospital No. 52, Moscow, Russia., Petrenko AA; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation.; Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, Russia., Baryakh EA; City Clinical Hospital No. 52, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Yatskov KV; City Clinical Hospital No. 52, Moscow, Russia., Dmitrieva EA; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Misurina EN; City Clinical Hospital No. 52, Moscow, Russia., Nikitin KE; Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, Russia., Vasilieva EJ; Davidovsky City Clinical Hospital, Moscow, Russia., Samsonova IV; City Clinical Hospital No. 52, Moscow, Russia., Ptushkin VV; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Baranova A; School of Systems Biology, George Mason University, Fairfax, VA, USA.; Research Center for Medical Genetics, Moscow, Russia., Nikitin EA; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jul; Vol. 63 (7), pp. 1607-1616. Date of Electronic Publication: 2022 Feb 13.
Autor:
Klepach AN; Institute of Economic Forecasting, Russian Academy of Sciences, Moscow, Russia., Vodovatov LB; Research and Expert Review Institute, Vnesheconombank of the Russian Federation, Moscow, Russia., Dmitrieva EA; Research and Expert Review Institute, Vnesheconombank of the Russian Federation, Moscow, Russia.
Publikováno v:
Studies on Russian economic development [Stud Russ Econ Dev] 2022; Vol. 33 (6), pp. 631-644. Date of Electronic Publication: 2022 Nov 28.
Autor:
Pochtar EV; Russian Medical Academy of professional continuous education., Lugovskaya SA; Russian Medical Academy of professional continuous education., Naumova EV; Russian Medical Academy of professional continuous education., Dmitrieva EA; S.P. Botkin Municipal Clinical Hospital., Kostin AI; Research Institute of emergency by Sklifosovsky., Dolgov VV; Russian Medical Academy of professional continuous education.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2021 Jun 07; Vol. 66 (6), pp. 345-352.
Autor:
Dmitrieva EA; City Clinical Hospital named after S.P. Botkin, Moscow, Russia., Nikitin EA; City Clinical Hospital named after S.P. Botkin, Moscow, Russia., Ignatova AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Vorobyev VI; City Clinical Hospital named after S.P. Botkin, Moscow, Russia., Poletaev AV; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Seregina EA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Voronin KA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Polokhov DM; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Maschan AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Novichkova GA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Panteleev MA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences, Moscow, Russia.; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia.; Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia., Ptushkin VV; City Clinical Hospital named after S.P. Botkin, Moscow, Russia.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Oct; Vol. 18 (10), pp. 2672-2684.